Due Diligence and Art

Due Diligence and Art

Share this post

Due Diligence and Art
Due Diligence and Art
Clinical Trials in the UK are Down by 44% Primarily Due to Lack of Participants

Clinical Trials in the UK are Down by 44% Primarily Due to Lack of Participants

The public trust in pharma is vanishing. This is good news.

Sasha Latypova's avatar
Sasha Latypova
Mar 02, 2023
∙ Paid
292

Share this post

Due Diligence and Art
Due Diligence and Art
Clinical Trials in the UK are Down by 44% Primarily Due to Lack of Participants
122
1
Share

According to a recent article by Endpoints News, the clinical trials industry in the UK is in shambles:

From 2017 to 2021, there was a 44% drop in recruitment of patients to commercial clinical trials and a 48% decline in the number of Phase III industry trials initiated in the UK. The UK fell in global ranking from fourth in 2017 for Phase III industry …

Keep reading with a 7-day free trial

Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Sasha Latypova
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share